Costs associated with febrile neutropenia in solid tumor and lymphoma patients – an observational study in Singapore

Table 5 Factors associated with the total hospital cost in a regression model (n=367) ^a

Variables^b	Unstandardized coefficient (B)	95% CI for B		Standard error	Standardized coefficient (B)	p value^c
Variables^b	Unstandardized coefficient (B)	Lower bound	Upper bound	Standard error	Standardized coefficient (B)	p value^c
Length of stay	0.061	0.056	0.065	0.002	0.763	< 0.001
Time to ANC recovery	0.003	-0.003	0.009	0.003	0.024	0.363
ANC at presentation	0.008	-0.054	0.070	0.031	0.007	0.797
MASCC score < 21	-0.013	-0.052	0.026	0.020	-0.017	0.513
Lymphoma	0.105	0.064	0.146	0.021	0.141	< 0.001
Male gender	0.026	-0.006	0.059	0.016	0.042	0.110
Severe sepsis	0.131	0.086	0.176	0.023	0.154	< 0.001
Inpatient referral	0.038	-0.008	0.083	0.023	0.043	0.107

a. Adjusted R² = 0.782, p < 0.001; b. Only clinically relevant variables that were statistically significant at p value of 0.05 in the univariate analysis were included in the regression model; c. Bolded p values are statistically significant; ANC = absolute neutrophil count; MASCC = Multinational Association of Supportive Care in Cancer.

ISSN: 1472-6963